Investing in the Future
AT DUKE CANCER INSTITUTE (DCI), we strive to be the employer of choice for professionals in cancer fields and to ensure that the next generation of physicians and scientists represents the communities we serve. A diverse cancer workforce improves patient outcomes and leads to creative solutions and novel approaches in cancer research and patient care.
In this issue of Breakthroughs, you will meet just a few of the people working to invigorate the cancer workforce, as well as a student pursuing her goal of earning a PhD in integrative immunobiology thanks to a federally funded DCI effort aimed at bringing more recent college graduates into the sciences.
Also in this issue, you’ll learn one way in which DCI is continuing to innovate in treating the whole person, not just the cancer. An initial clinical trial of a new structured support program to help young adults successfully manage their new lives as cancer survivors helped researcher Caroline Dorfman, PhD, win a MERIT award from the National Institutes of Health to conduct a larger trial of this intervention. This long-term grant recognizes exceptional researchers whose work shows significant promise.
None of these efforts, and many others, would be possible without our donors and friends. Thank you for all that you do in helping us shape the future of cancer care and research.
Michael B. Kastan, MD, PhD
Executive Director, Duke Cancer Institute
William and Jane Shingleton Professor of Pharmacology and Cancer Biology
This article was originally published in the Fall 2024 Breakthroughs. Read more about DCI's breakthrough research and patient care in this biannual magazine.